{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:37:45Z","timestamp":1791027465167,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1124\/jpet.102.048249","type":"journal-article","created":{"date-parts":[[2003,4,19]],"date-time":"2003-04-19T03:13:41Z","timestamp":1050722021000},"page":"653-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Activation of \u03b22- and \u03b23-Adrenergic Receptors Increases Brain Tryptophan"],"prefix":"10.1016","volume":"305","author":[{"given":"Natalie R.","family":"Lenard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Gettys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.048249_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(02)01421-8","article-title":"\u03b23-Adrenoceptor agonists: potential, pitfalls and progress.","volume":"440","author":"Arch","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/309163a0","article-title":"Atypical \u03b2-adrenoceptor on brown adipocytes as target for anti-obesity drugs.","volume":"309","author":"Arch","year":"1984","journal-title":"Nature (Lond)"},{"key":"10.1124\/jpet.102.048249_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(95)00802-0","article-title":"A specific \u03b23-adrenoceptor agonist induces increased pancreatic islet blood flow and insulin secretion in rats.","volume":"298","author":"Atef","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib4","doi-asserted-by":"crossref","first-page":"E1158","DOI":"10.1152\/ajpendo.2000.278.6.E1158","article-title":"Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice.","volume":"278","author":"Banks","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.102.048249_bib5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000054276","article-title":"Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and \u03b2-adrenoceptors.","volume":"8","author":"Ben-Eliyahu","year":"2000","journal-title":"Neuroimmunomodulation"},{"key":"10.1124\/jpet.102.048249_bib6","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1021\/jm00094a025","article-title":"Disodium (R, R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent \u03b2-adrenergic agonist virtually specific for \u03b23 receptors. A promising antidiabetic and antiobesity agent.","volume":"35","author":"Bloom","year":"1992","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.102.048249_bib7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1476-5381.1983.tb10542.x","article-title":"\u03b2-Adrenoceptor heterogeneity in guinea-pig airways: comparison of functional and receptor labelling studies.","volume":"79","author":"Carswell","year":"1983","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1476-5381.1985.tb09432.x","article-title":"Effects of conditioned running on plasma, liver and brain tryptophan and on brain 5-hydroxytryptamine metabolism of the rat.","volume":"86","author":"Chaouloff","year":"1985","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/PL00005050","article-title":"The \u03b23-adrenoceptor agonist SR58611A inhibits gastric acid secretion in the conscious cat.","volume":"356","author":"Coruzzi","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s002130000618","article-title":"Discriminative stimulus effects of centrally administered isoproterenol in rats: mediation by \u03b2-1 adrenergic receptors.","volume":"154","author":"Crissman","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl","key":"10.1124\/jpet.102.048249_bib11","first-page":"81","article-title":"Relationships between plasma, CSF and brain tryptophan.","volume":"15","author":"Curzon","year":"1979","journal-title":"J Neural Transm"},{"key":"10.1124\/jpet.102.048249_bib12","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/j.1471-4159.1972.tb01486.x","article-title":"Effects of immobilization and food deprivation on rat brain tryptophan metabolism.","volume":"19","author":"Curzon","year":"1972","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.102.048249_bib13","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/0024-3205(88)90023-9","article-title":"Changes in plasma and brain tryptophan and brain serotonin and 5- hydroxyindoleacetic acid after footshock stress.","volume":"42","author":"Dunn","year":"1988","journal-title":"Life Sci"},{"key":"10.1124\/jpet.102.048249_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1471-4159.1988.tb01053.x","article-title":"Stress-related changes in cerebral catecholamine and indoleamine metabolism: lack of effect of adrenalectomy and corticosterone.","volume":"51","author":"Dunn","year":"1988","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.102.048249_bib15","series-title":"Neurobiology of Cytokines","first-page":"209","article-title":"Neurochemical methods for evaluating cerebral biogenic amine responses to cytokines and their involvement in the central actions of interleukin-1","author":"Dunn","year":"1993"},{"key":"10.1124\/jpet.102.048249_bib16","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/j.1471-4159.1991.tb06359.x","article-title":"Stress- and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity.","volume":"57","author":"Dunn","year":"1991","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.102.048249_bib17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0024-3205(88)90659-5","article-title":"Effects of imipramine on tyrosine and tryptophan are mediated by \u03b2-adrenoceptor stimulation.","volume":"42","author":"Edwards","year":"1988","journal-title":"Life Sci"},{"key":"10.1124\/jpet.102.048249_bib18","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1016\/0006-2952(89)90003-8","article-title":"Effects of the \u03b22-adrenoceptor agonist clenbuterol on tyrosine and tryptophan in plasma and brain of the rat.","volume":"38","author":"Edwards","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib19","doi-asserted-by":"crossref","first-page":"PL13","DOI":"10.1016\/0024-3205(90)90621-W","article-title":"Hypoaminoacidemia caused by imipramine but not clenbuterol is dissociable from hyperglycemia and hyperinsulinemia.","volume":"47","author":"Edwards","year":"1990","journal-title":"Life Sci"},{"key":"10.1124\/jpet.102.048249_bib20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF00515567","article-title":"\u03b2-Adrenoceptor subtypes in sections of rat and guinea pig kidney.","volume":"328","author":"Engel","year":"1985","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/0024-3205(88)90436-5","article-title":"\u03b2-adrenergic control of brain uptake of large neutral amino acids.","volume":"42","author":"Eriksson","year":"1988","journal-title":"Life Sci"},{"key":"10.1124\/jpet.102.048249_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-5793(99)00049-6","article-title":"The role of the sympathetic nervous system in the regulation of leptin synthesis in C57BL\/6 mice.","volume":"444","author":"Evans","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.102.048249_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1476-5381.1996.tb15176.x","article-title":"Expression of \u03b23-adrenoceptor mRNA in rat tissues.","volume":"117","author":"Evans","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib24","first-page":"1151","article-title":"The effect of nutritional factors on brain amino acid levels and monoamine synthesis.","volume":"35","author":"Fernstrom","year":"1976","journal-title":"Fed Proc"},{"key":"10.1124\/jpet.102.048249_bib25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1152\/physrev.1983.63.2.484","article-title":"Role of precursor availability in control of monoamine biosynthesis in brain.","volume":"63","author":"Fernstrom","year":"1983","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.102.048249_bib26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1126\/science.178.4059.414","article-title":"Brain serotonin content: physiological regulation by plasma neutral amino acids.","volume":"178","author":"Fernstrom","year":"1972","journal-title":"Science (Wash DC)"},{"key":"10.1124\/jpet.102.048249_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1432-1033.1994.00761.x","article-title":"Antibodies for the immunochemistry of the human \u03b23-adrenergic receptor.","volume":"224","author":"Guillaume","year":"1994","journal-title":"Eur J Biochem"},{"issue":"Suppl","key":"10.1124\/jpet.102.048249_bib28","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1038\/sj.npp.1395336","article-title":"Activity of serotonergic neurons in behaving animals.","volume":"21","author":"Jacobs","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.102.048249_bib29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0773.1995.tb00166.x","article-title":"Different adrenergic receptor density in different rat skeletal muscle fibre types.","volume":"76","author":"Jensen","year":"1995","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/jpet.102.048249_bib30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1476-5381.1996.tb15209.x","article-title":"Functional identification of rat atypical \u03b2-adrenoceptors by the first \u03b23-selective antagonists, aryloxypropanolaminotetralins.","volume":"117","author":"Manara","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib31","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1476-5381.1984.tb16488.x","article-title":"The affinity and efficacy of the selective beta 1-adrenoceptor stimulant RO363 at \u03b21- and \u03b22-adrenoceptor sites.","volume":"82","author":"McPherson","year":"1984","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0026-895X(25)11403-X","article-title":"Simultaneous determination of \u03b2-1 and \u03b2-2-adrenergic receptors in tissues containing both receptor subtypes.","volume":"16","author":"Minneman","year":"1979","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1096\/fasebj.11.13.9367354","article-title":"Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood-brain barrier.","volume":"11","author":"Muruganandam","year":"1997","journal-title":"FASEB J"},{"key":"10.1124\/jpet.102.048249_bib34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0165-6147(97)90634-9","article-title":"Pharmacological properties of \u03b23-adrenoceptors.","volume":"18","author":"Nisoli","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.102.048249_bib35","first-page":"227","article-title":"Responses to the \u03b22-selective agonist procaterol of vascular and atrial preparations with different functional \u03b2-adrenoceptor populations.","volume":"84","author":"O\u2019Donnell","year":"1985","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/REVNEURO.1997.8.2.117","article-title":"A critical review of 5-HT brain microdialysis and behavior.","volume":"8","author":"Rueter","year":"1997","journal-title":"Rev Neurosci"},{"key":"10.1124\/jpet.102.048249_bib37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00000441-198710000-00005","article-title":"The pharmacology of dobutamine.","volume":"294","author":"Ruffolo","year":"1987","journal-title":"Am J Med Sci"},{"key":"10.1124\/jpet.102.048249_bib38","first-page":"123","article-title":"\u03b23-adrenergic receptor agonists as anti-obese and anti-diabetic drugs.","volume":"60","author":"Sakura","year":"2002","journal-title":"Nippon Rinsho"},{"key":"10.1124\/jpet.102.048249_bib39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3109\/00498258409151466","article-title":"Autoradiography of nadolol and propranolol in the rat.","volume":"14","author":"Schiff","year":"1984","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.102.048249_bib40","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1074\/jbc.274.17.12017","article-title":"The \u03b23-adrenergic receptor activates mitogen-activated protein kinase in adipocytes through a Gi-dependent mechanism.","volume":"274","author":"Soeder","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.102.048249_bib41","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1476-5381.1995.tb17205.x","article-title":"Expression of \u03b23-adrenoceptor mRNA in rat brain.","volume":"116","author":"Summers","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib42","doi-asserted-by":"crossref","first-page":"29483","DOI":"10.1074\/jbc.270.49.29483","article-title":"Targeted disruption of the \u03b23-adrenergic receptor gene.","volume":"270","author":"Susulic","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.102.048249_bib43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0014-2999(92)90034-2","article-title":"\u03b2-Adrenergic regulation of amine precursor amino acid transport across the blood-brain barrier.","volume":"215","author":"Takao","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib44","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI110208","article-title":"Selectivity of dobutamine for adrenergic receptor subtypes.","volume":"67","author":"Williams","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.102.048249_bib45","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/0006-2952(76)90400-7","article-title":"Control of brain neurotransmitter synthesis by precursor availability and nutritional state.","volume":"25","author":"Wurtman","year":"1976","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.102.048249_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.RES.84.1.43","article-title":"Coupling of \u03b22-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes.","volume":"84","author":"Xiao","year":"1999","journal-title":"Circ Res"},{"key":"10.1124\/jpet.102.048249_bib47","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2337\/diabetes.48.5.1006","article-title":"cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets.","volume":"48","author":"Yajima","year":"1999","journal-title":"Diabetes"},{"key":"10.1124\/jpet.102.048249_bib48","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0091-3057(90)90088-Y","article-title":"Central beta 1-adrenergic receptors are involved in CRF-induced defensive withdrawal.","volume":"36","author":"Yang","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.102.048249_bib49","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/01.CIR.101.6.682","article-title":"Antisense inhibition of beta-1-adrenergic receptor mRNA in a single dose produces a profound and prolonged reduction in high blood pressure in spontaneously hypertensive rats.","volume":"101","author":"Zhang","year":"2000","journal-title":"Circulation"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652436330X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652436330X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.048249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:43:38Z","timestamp":1740008618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652436330X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["S002235652436330X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.048249","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2003,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of \u03b22- and \u03b23-Adrenergic Receptors Increases Brain Tryptophan","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.048249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}